$CYRX News

Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026

CryoPort Q2 2026 Earnings Call Transcript

BTIG Maintains Buy on CryoPort, Raises Price Target to $26

Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?

Guggenheim Maintains Buy on CryoPort, Raises Price Target to $19

Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals

BTIG Reiterates Buy on CryoPort, Maintains $25 Price Target

Cryoport (CYRX) Stock Fair Value Rises After Analysts Lift Growth Assumptions

Cryoport (CYRX) Q2 2026 Earnings Call Transcript

CryoPort (CYRX) Upgraded to Buy: Here's Why

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

Investor Confidence in CryoPort (CYRX) Strengthened Backed by Pipeline Expansion

Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16

Cryoport, Inc. Q2 2026 Earnings Call Summary

Needham Maintains Buy on CryoPort, Raises Price Target to $19

CryoPort Inc (CYRX) (Q2 2026) Earnings Call Highlights: Positive EBITDA Milestone and 15% ...

CryoPort Q2 Earnings Call Highlights

Cryoport, Inc. 2026 Q2 - Results - Earnings Call Presentation

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

Cryoport (NASDAQ:CYRX) Reports In-Line Q2 Results as Stock Edges Higher